The Global Market for Nanobiotechnology is Projected to Reach US$39.4 Billion by 2022
Advancements in Nanomedicine Research Provides the
Platform for Growth of Nanobiotechnology, According to a New Report by Global Industry Analysts, Inc.
GIA launches
comprehensive analysis of industry segments, trends, growth drivers, market
share, size and demand forecasts on the global Nanobiotechnology market. The
global market for Nanobiotechnology is projected to reach US$39.4 billion by
2022, driven by growing R&D efforts directed at enabling the
development of diverse nanotech-based solutions in nanomedicine and other medical
science fields.
Nanobiotechnology,
a sub-segment of nanotechnology, is a combination of molecular engineering,
chemistry, biotechnology, biology and physical sciences. By reapplying the
success of nanotechnology into the field of biology, market participants are
keen on crossing the threshold of this next frontier by developing tools to
explore the proteins contained within a cell to architecture a communication
channel between physical objects such as electronic devices, and living matter
such as cells, and neurons. Nanobiotechnology is increasingly used in life
sciences research, particularly in cell-level research which has the potential
to enhance nanobiotechnology’s role in pharma and healthcare. Nanobiotechnology today stands optimally positioned to
extend its clout into biotechnology (drug delivery, tissue engineering, drug
discovery, diagnostics, implantable devices, and imaging agents), pharmacy,
medicine, and health.
The technology is forecast to
tailspin modern day healthcare by revolutionizing every facet of health,
diagnostics, and treatment, by making it more efficient, focused,
target-specific, and less invasive. Competitive strongpoints driving the
success of nanobiotechnology include ability to control and manipulate
nanoscale chemical and structural building blocks of life i.e. molecules; and rapid
strides in nanoparticle
synthesis. The technology is revered for its ability to open up
new possibilities for intracellular drug delivery and fortify the ability of
the medical community to battle against several
fatal diseases such as cancer, AIDS, and various neurological and cardiovascular disorders. Factors such as increased
research funding, transfer of technological know-how, continuously rising chronic
diseases prevalence, and breakthrough developments that unlock the potential of
nanomedicine
for resolving some of the unmet needs in the medical field are other major growth
drivers.
As stated by
the new market research report on Nanobiotechnology, the United States represents the largest
market worldwide. Rest of World comprising Asia-Pacific, Latin America, the
Middle East, Africa and Canada constitutes the fastest growing market,
flaunting a CAGR of 10.5% over the analysis period. Among the emerging regions,
Asia-Pacific represents an important market driven by developments in the area
of healthcare technologies and infrastructure, and increased acceptance of new
treatment technologies. Latin America represents the other major market with
several major companies like J&J and Novartis among others expanding their
operations in Mexico, Brazil and other Latin American countries.
Leading players
in the market include Ablynx NV, Arrowhead Pharmaceuticals Inc., CaPtivate
Pharmaceuticals LLC, Celgene Corporation, ELITechGroup, Flamel Technologies SA,
GlaxoSmithKline Plc., Johnson & Johnson, Merck & Co. Inc., NanoBio®
Corporation, Nanophase Technologies Corporation, pSivida Corp., Sigma-Aldrich
Corp., Starpharma Holdings Ltd., and Vectura Group plc, among others.
The research report titled “Nanobiotechnology:
A Global Strategic Business Report” announced by Global Industry Analysts
Inc., provides a comprehensive review of market trends, growth drivers,
innovations and strategic industry activities of major companies worldwide. The
report provides market estimates and projections in value terms for all major
geographic markets including the US, Japan, Europe and Rest of World.
Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA,
All Rights Reserved.
Comments
Post a Comment